| Recruitment status | Open public recruiting |
| Unique ID issued by UMIN | UMIN000017524 |
| Receipt No. | R000020008 |
| Official scientific title of the study | Effectiveness of Transcatheter arterial micro-emblization for nighttime shoulder pain |
| Date of disclosure of the study information | 2015/05/13 |
| Last modified on | 2016/05/06 (Ver. 4) |
| Basic information | ||
| Official scientific title of the study | Effectiveness of Transcatheter arterial micro-emblization for nighttime shoulder pain | |
| Title of the study (Brief title) | TAME for nighttime shoulder pain | |
| Region |
|
|
| Condition | ||
| Condition | nighttime shoulder pain refractory to traditional managements | |
| Classification by specialty |
|
|
| Classification by malignancy | Others | |
| Genomic information | NO | |
| Objectives | |
| Narrative objectives1 | To investigate the feasibility and effectiveness of transcatheter arterial micro-embolization for nighttime shoulder pain |
| Basic objectives2 | Safety,Efficacy |
| Basic objectives -Others | |
| Trial characteristics_1 | |
| Trial characteristics_2 | |
| Developmental phase | Phase I,II |
| Assessment | |
| Primary outcomes | VAS
Pittsburgh Sleep Quality Index |
| Key secondary outcomes | Pain Catastolophsing Scale
Serum CRP shoulder functional score (ASES) Ultrasonographic findings |
| In outcomes field, the entry of just a few words such as "safety" or "efficiency" will not be accepted. Specify the name of outcome measures, including the time when you plan to measure. Usually, only one primary outcome is accepted. Write the other outcomes in "secondary outcomes" field. |
| Base | |
| Study type | Interventional |
| Study design | |
| Basic design | Single arm |
| Randomization | Non-randomized |
| Randomization unit | |
| Blinding | Open -no one is blinded |
| Control | Uncontrolled |
| Stratification | |
| Dynamic allocation | |
| Institution consideration | |
| Blocking | |
| Concealment | |
| Intervention | ||
| No. of arms | 1 | |
| Purpose of intervention | Treatment | |
| Type of intervention |
|
|
| Interventions/Control_1 | Transcatheter arterial micro-embolization | |
| Interventions/Control_2 | ||
| Interventions/Control_3 | ||
| Interventions/Control_4 | ||
| Interventions/Control_5 | ||
| Interventions/Control_6 | ||
| Interventions/Control_7 | ||
| Interventions/Control_8 | ||
| Interventions/Control_9 | ||
| Interventions/Control_10 | ||
| In interventions field, include the details of interventions, such as duration, amount, and frequency. If the intervention includes prescription or use of medical devices, duration is required. |
| Eligibility | ||||
| Age-lower limit |
|
|||
| Age-upper limit |
|
|||
| Gender | Male and Female | |||
| Key inclusion criteria | Musculoskeletal shoulder pain
Nighttime shoulder pain VAS >49mm Pitsuberg sleep score > 5 Receive conservative treatments for more than 3 motnhs |
|||
| Key exclusion criteria | previous shouder surgery
advansed arteriosclerosis pregnancy reumatoid arthritis major depression malignant tumor |
|||
| Target sample size | 50 | |||
| Research contact person | |
| Name of lead principal investigator | Yuji Okuno |
| Organization | Edogawa Hospital |
| Division name | Musculoskeletal Intervention center |
| Address | Higashikoiwa 2-24-18 Edogawa-ku, Tokyo, Japan |
| TEL | 03-3673-1221 |
| how_lowlow@yahoo.co.jp | |
| Public contact | |
| Name of contact person | Miku Sato |
| Organization | Edogawa Hospital |
| Division name | Orthopedic Surgery |
| Address | Higashikoiwa 2-24-18 Edogawa-ku, Tokyo, Japan |
| TEL | 03-3673-1221 |
| Homepage URL | |
| secretary6@edogawa.or.jp | |
| Sponsor | |
| Institute | Edogawa musculoskeletal intervention study group |
| Institute | |
| Department | |
| Sponsor means an organization that is responsible for plan, deployment and report of the research including funding management. It doesn't mean funding agency". Therefore, all clinical trial should have the one. |
| Funding Source | |
| Organization | Edogawa orthopedic surgery research funding |
| Organization | |
| Division | |
| Category of Funding Organization | Other |
| Nationality of Funding Organization | |
| Other related organizations | |
| Co-sponsor | |
| Name of secondary funder(s) | |
| Secondary IDs | |
| Secondary IDs | NO |
| Study ID_1 | |
| Org. issuing International ID_1 | |
| Study ID_2 | |
| Org. issuing International ID_2 | |
| IND to MHLW | |
| Institutions | |
| Institutions | |
| Other administrative information | |||||||
| Date of disclosure of the study information |
|
||||||
| Progress | |||||||
| Recruitment status | Open public recruiting | ||||||
| Date of protocol fixation |
|
||||||
| Anticipated trial start date |
|
||||||
| Last follow-up date | |||||||
| Date of closure to data entry | |||||||
| Date trial data considered complete | |||||||
| Date analysis concluded | |||||||
| Related information | |
| URL releasing protocol | |
| Publication of results | Unpublished |
| URL releasing results | |
| Results | |
| Other related information | |
| Management information | |||||||
| Registered date |
|
||||||
| Last modified on |
|
||||||
| Link to view the page | |
| URL(English) | https://upload.umin.ac.jp/cgi-open-bin/ctr_e/ctr_view.cgi?recptno=R000020008 |